Clinical Trials Browser

Phase 1 × NIH × enzastaurin × Clear all

NCT00108056 2019-12-05

Enzastaurin to Treat Recurrent Brain Tumor

Phase 1 Terminated

Brain Neoplasms, Glioma, Neoplasms, Disease Progression